Log in


  • Home
  • New Directions in Influenza Management: The pharmacist's guide to patient identification, testing, and antiviral use

New Directions in Influenza Management: The pharmacist's guide to patient identification, testing, and antiviral use

  • 26 Jan 2021
  • 7:00 PM - 8:00 PM
  • Virtual

Registration

  • Complimentary Registration must be received by noon on Monday, Jan. 25th to receive log in instructions. The survey code will be provided at the end of the webinar.
  • Register by and remit payment by Sunday, Jan. 24th to receive log in instructions. The survey code will be provided at the end of the webinar.

    If you join CSHP within a week of this program, we will refund your registration fee.

Register

Virtual CE Program

Tuesday, Jan. 26, 2021
New Directions in Influenza Management:

The pharmacist's guide to patient identification, testing, and antiviral use
 7:00 - 8:00 p.m.

Speaker: Karen Lusardi, PharmD, Clinical Pharmacy Specialist, Antimicrobial Stewardship
UAMS Medical Center, Little Rock, AR

Differentiating influenza from other viruses, and treating high-risk patients in a timely manner to avoid over- burdening the healthcare system, has never been more relevant. Join us for a timely, expert-led CPE program that will marry the current data and guideline recommendations on influenza testing, diagnosis, and antiviral treatment with engaging whiteboard animation case studies, so you are prepared to apply the latest updates in influenza to clinical practice now.

Educational Objectives   Upon proper completion of this activity, participants should be better able to:
  • Identify appropriate candidates for antiviral therapy based on risk for influenza-related complications, in accordance with current guideline recommendations
  • Assess the need for influenza treatment based on patient signs, symptoms, and accurate interpretation of appropriate diagnostic tests when necessary
  • Recommend individualized antiviral treatment plans for patients with, or at risk for, influenza in accordance with the latest evidence

Please register no later than noon, Monday, Jan. 25, 2021
Information on how to log into the program will be emailed to you on Jan. 25th.

Complimentary registration
for current CSHP members

$25 for non-members: Payment must be received by Jan 24, 2021 but will be refunded
if you join CSHP within two weeks of the program's presentation.

This activity is supported by an educational grant from Genentech, a member of the Roche Group.

1 live credit hour: This CE activity is jointly provided by ProCE, Inc. and Paradigm Medical Communications, LLC. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Numbers 0221-9999-20-243-L01-P  0221-9999-20-243-L01-PT has been assigned to this live knowledge-based CE activity. This activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. Completion of the evaluation and the post-test are required to receive CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given..

Logging instructions and survey codes will be provided during the program...

Questions about logging: Erin Pennington, Program Manager, Medical Therapeutics Group; Paradigm Medical Communications, LLC at 516-582-8787  epennington@paradigmmc.com

About CSHP

Since 1948, the Connecticut Society of Health-System Pharmacists has represented the professional interests and provided professional development for CT pharmacists, educators and pharmacists in training.

Contacts

c/o The Association Advantage, LLC

591 North Avenue

Suite 3-2

Wakefield, MA 01880-1617

Phone - Toll-free: (888) 506-3784 (506-DRUG)


Copyright © You can place your copyright information here.
Powered by Wild Apricot Membership Software